Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: Behav Modif. 2019 Mar 31;44(4):552–579. doi: 10.1177/0145445519838828

Table 1.

Participant Characteristics

Participant Age (yrs) Education (yrs) Sex Side of MotorSymptom Onset MDS-UPDRS (motor score) Disease Duration (yrs) Anxiety/Depression Diagnosis (CSR) In-person vs. Internet-delivered Tx Baseline Length (weeks)
P1 67 18 F Right 23 4.4 GAD (4) In-person 2
P2 55 14 M Right 18 3.5 PD (4) In-person 4
P3 65 16 M Right 40 15.4 GAD (5); DYS (5) In-person 6
P4 79 18 M Bilateral 54 7.9 OTHER SPEC ANX (LSA) (6); SOC (5) In-person 2
P5 59 16 F Right 24 4.9 PD (5); AG (6); GAD (4) Internet 4
P6 64 20+ M Left 31 10.4 SOC (4) Internet 6
P7 56 14 F Right 21 1.6 SOC (5); GAD (5) Internet 2
P8 33 19 F Left 30 9.0 PD (6); AG (6); SOC (6); GAD (6); MDD (5) In-person 4
P9 73 16 F Left 11 2.5 GAD (4) Internet 6

MDS-UPDRS=Unified Parkinson’s Disease Rating Scale (participants tested in “on” state); CSR = Clinical Severity Rating; GAD = generalized anxiety disorder; SOC = social anxiety disorder; LSA=limited-symptom panic attack; DYS=dysthymia; PD=panic disorder. MDD=major depressive disorder. Tx=Treatment. Only clinically significant anxiety/depression diagnoses (CSR ≥4) are reported.